Table 5: Intramural historical comparisons of observed 5-year survival rates by cancer types for consecutive time periods.

 

CANCER

1989-1995

1996-2003

1989-1995 Med Surv Mos

1996-2003 Med Surv Mos

1989-1995

5-yr surv %

1996-2003

5-yr surv %

P val KM

 BREAST

1375

2391

NR

NR

82

86

.002

GYNECOLOGIC

 

 

 

 

 

 

 

   Cervix

186

157

NR

NR

72

70

.753

   Uterus

212

411

NR

NR

73

77

.147

   Ovary(no borderline)

213

279

37

45

40

45

.180

GASTROINTESTINAL

 

 

 

 

 

 

 

    Colon

479

797

64

80

51

56

.142

    Rectal-RS

175

350

93

105

63

66

.472

   Esophagus 

71

97

5

11

14

17

.413

   Liver & other biliary

44

120

5

7

5

15

.0008

   Pancreas

176

263

6

8

3

6

.664

   Stomach

84

149

13

16

14

19

.289

 UROLOGIC

 

 

 

 

 

 

 

    Prostate

1114

1915

NR

NR

80

88

<.0001

    Bladder w/ in situ

292

487

NR

109

74

68

.683

    Kidney & Renal Pelvis

140

251

72

90

51

55

.408

    Testis

83

89

NR

NR

95

97

.545

HEAD & NECK

 

 

 

 

 

 

 

    Larynx

61

68

NR

105

66

62

.593

    Oral, Pharynx

147

226

76

99

55

60

.393

    Thyroid

85

309

NR

NR

95

95

.928

 

 

 

 

 

 

 

 

LUNG

1082

1627

12

14

18

24

.004

MELANOMA of skin

313

595

NR

NR

78

80

.449

BRAIN

82

255

15

15

28

23

.642

HEMATOLOGIC

 

 

 

 

 

 

 

    Leukemia

164

329

15

27

30

41

.015

    Lymphoma-NHL

319

480

50

107

46

59

.0003

    Myeloma

65

116

30

45

28

36

.116

    Hodgkin’s

63

80

NR

NR

85

85

.928

ALL Invasive   

7,662

12,977

87

120

56

62

<.0001

NR=not reached.